Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Iluvien: a new sustained delivery technology for posterior eye disease.

Kane FE, Burdan J, Cutino A, Green KE.

Expert Opin Drug Deliv. 2008 Sep;5(9):1039-46. doi: 10.1517/17425247.5.9.1039 . Review.

PMID:
18754752
2.

Fluocinolone acetonide implantable device for diabetic retinopathy.

Schwartz SG, Flynn HW Jr.

Curr Pharm Biotechnol. 2011 Mar 1;12(3):347-51. Review.

PMID:
20939799
3.

[Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].

Soubrane G, Behar-Cohen F.

J Fr Ophtalmol. 2015 Feb;38(2):159-67. doi: 10.1016/j.jfo.2014.09.007. Epub 2015 Jan 16. Review. French.

4.

Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation.

Sadiq MA, Agarwal A, Soliman MK, Hanout M, Sarwar S, Do DV, Nguyen QD.

Expert Opin Drug Saf. 2015 Jul;14(7):1147-56. doi: 10.1517/14740338.2015.1041916. Epub 2015 May 20. Review.

PMID:
25994877
5.

Fluocinolone acetonide for the treatment of diabetic macular edema.

Haritoglou C, Mayer W, Wolf A.

Expert Rev Clin Pharmacol. 2016;9(3):367-74. doi: 10.1586/17512433.2016.1133287. Epub 2016 Jan 15. Review.

PMID:
26681198
6.

Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema.

Syed YY.

Drugs. 2017 Apr;77(5):575-583. doi: 10.1007/s40265-017-0722-4. Review.

PMID:
28283896
7.

Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema.

Sanford M.

Drugs. 2013 Feb;73(2):187-93. doi: 10.1007/s40265-013-0010-x. Review.

PMID:
23335133
8.

A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND).

Figueira J, Henriques J, Amaro M, Rosas V, Alves D, Cunha-Vaz J.

Ophthalmic Res. 2017;57(3):166-172. doi: 10.1159/000455235. Epub 2017 Feb 9.

PMID:
28178701
9.
10.

Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes.

Kumar A, Alfahad Q, Mitra A, Elsherbiny S, Lip PL.

Eye (Lond). 2016 May;30(5):763-4. doi: 10.1038/eye.2015.281. Epub 2016 Jan 22. No abstract available. Erratum in: Eye (Lond). 2016 May;30(5):770.

11.

Drug delivery methods for posterior segment disease.

Hsu J.

Curr Opin Ophthalmol. 2007 May;18(3):235-9. Review.

PMID:
17435432
12.

Quantitative Assessment of Optic Nerve Changes in Patients With Diabetic Macular Edema Treated With Fluocinolone Acetonide Vitreous Implants.

Parrish RK 2nd, Traverso CE, Green K, Danis RP; FAME Study Group.

Ophthalmic Surg Lasers Imaging Retina. 2016 May 1;47(5):418-25. doi: 10.3928/23258160-20160419-04.

PMID:
27183545
13.

Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants.

Campochiaro PA, Nguyen QD, Hafiz G, Bloom S, Brown DM, Busquets M, Ciulla T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane FE; FAMOUS Study Group.

Ophthalmology. 2013 Mar;120(3):583-7. doi: 10.1016/j.ophtha.2012.09.014. Epub 2012 Dec 4.

PMID:
23218184
14.

Economic evaluation of a fluocinolone acetonide intravitreal implant for patients with DME based on the FAME study.

Cutino A, Green K, Kendall R, Moore PT, Zachary C.

Am J Manag Care. 2015 Jan;21(4 Suppl):S63-72.

15.

The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.

Nentwich MM, Ulbig MW.

Dtsch Arztebl Int. 2012 Sep;109(37):584-90. doi: 10.3238/arztebl.2012.0584. Epub 2012 Sep 14. Review.

16.

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.

Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, Lavaque AJ, Larson RJ.

Ophthalmology. 2009 May;116(5):902-11; quiz 912-3. doi: 10.1016/j.ophtha.2009.02.002. Review.

PMID:
19410949
17.

Introduction.

Puliafito CA.

Ophthalmic Surg Lasers Imaging Retina. 2016 Apr;47(4 Suppl):S4. doi: 10.3928/23258160-20160401-01. No abstract available.

PMID:
27096288
18.

Intravitreal inserts of steroids to treat diabetic macular edema.

Montero JA, Ruiz-Moreno JM.

Curr Diabetes Rev. 2009 Feb;5(1):26-32. Review.

PMID:
19199895
19.

Biodegradable intraocular therapies for retinal disorders: progress to date.

Kuno N, Fujii S.

Drugs Aging. 2010 Feb 1;27(2):117-34. doi: 10.2165/11530970-000000000-00000. Review.

PMID:
20104938
20.

[Intravitreal triamcinolone for diabetic macular oedema. Method and complications].

Zamfir C.

Oftalmologia. 2009;53(1):100-5. Review. Romanian.

PMID:
19569613

Supplemental Content

Support Center